Abstract
Magnetite (Fe3O4), is an extensively studied material because of several interesting properties and associated applications. However, synthesizing functional magnetite nano- and microstructures as ferrofluids for use in biomedical field still remains a challenge due to the technical limitations associated with the fabrication process. We have developed a one-step, low energy consumable process for the synthesis of highly monodisperse magnetite nanoparticles using thioglycerol as a stabilizing agent. The characterization of synthesized nanoparticles has been carried out using particle size analyzer, Transmission electron microscopy (TEM), X-ray diffractometry (XRD) and Fourier transform infrared spectrometry (FTIR). The antibacterial property of the synthesized magnetite nanoparticles has also been investigated and the results indicated that the tested pathogenic microorganisms are quite susceptible to very low concentrations of thioglycerol stabilized magnetite nanoparticles (TSMNs). The minimum inhibitory concentrations of synthesized TSMNs were found to be 0.041 mg/ml for E. coli and 0.047mg/ml for Staphylococcus aureus, Bacillus subtilis and Pseudomonas aeruginosa. Such antibacterial properties pose great promise for nanomaterials stabilized with organic molecules to be used in bio-medical applications.
Keywords: Antibacterial activity, magnetite, MIC, nanoparticles, stabilization, thioglycerol, Fe3O4, TEM, XRD, FTIR, NCIM, ATCC, MHA, KBr, JCPDS, DLS, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, Escherischia coli, SH group, antibiotics, Gram-positive, Gram-negative, NEERI
Current Nanoscience
Title: Synthesis and Broad Spectrum Antibacterial Activity of Magnetite Ferrofluid
Volume: 6 Issue: 6
Author(s): Charusheela Ramteke, Bijaya Ketan Sarangi, Tapan Chakrabarti, Sandeep Mudliar, Dewanand Satpute and Ram Avatar Pandey
Affiliation:
Keywords: Antibacterial activity, magnetite, MIC, nanoparticles, stabilization, thioglycerol, Fe3O4, TEM, XRD, FTIR, NCIM, ATCC, MHA, KBr, JCPDS, DLS, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, Escherischia coli, SH group, antibiotics, Gram-positive, Gram-negative, NEERI
Abstract: Magnetite (Fe3O4), is an extensively studied material because of several interesting properties and associated applications. However, synthesizing functional magnetite nano- and microstructures as ferrofluids for use in biomedical field still remains a challenge due to the technical limitations associated with the fabrication process. We have developed a one-step, low energy consumable process for the synthesis of highly monodisperse magnetite nanoparticles using thioglycerol as a stabilizing agent. The characterization of synthesized nanoparticles has been carried out using particle size analyzer, Transmission electron microscopy (TEM), X-ray diffractometry (XRD) and Fourier transform infrared spectrometry (FTIR). The antibacterial property of the synthesized magnetite nanoparticles has also been investigated and the results indicated that the tested pathogenic microorganisms are quite susceptible to very low concentrations of thioglycerol stabilized magnetite nanoparticles (TSMNs). The minimum inhibitory concentrations of synthesized TSMNs were found to be 0.041 mg/ml for E. coli and 0.047mg/ml for Staphylococcus aureus, Bacillus subtilis and Pseudomonas aeruginosa. Such antibacterial properties pose great promise for nanomaterials stabilized with organic molecules to be used in bio-medical applications.
Export Options
About this article
Cite this article as:
Ramteke Charusheela, Ketan Sarangi Bijaya, Chakrabarti Tapan, Mudliar Sandeep, Satpute Dewanand and Avatar Pandey Ram, Synthesis and Broad Spectrum Antibacterial Activity of Magnetite Ferrofluid, Current Nanoscience 2010; 6 (6) . https://dx.doi.org/10.2174/157341310793348605
DOI https://dx.doi.org/10.2174/157341310793348605 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy
Current Medicinal Chemistry Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Current Medicinal Chemistry Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting α-Secretase as an Alternative Drug Target for Treatment of Alzheimers Disease
Current Medicinal Chemistry The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
Current Pharmaceutical Design Recent Advances in the Development of MMPIs and APNIs Based on the Pyrrolidine Platforms
Mini-Reviews in Medicinal Chemistry Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents
Current Drug Targets Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Current Signal Transduction Therapy for Brain Tumors Review Article
Current Signal Transduction Therapy Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
Current Drug Therapy A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells
Current Alzheimer Research Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
Current Pharmaceutical Design Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
Current Molecular Pharmacology Pharmaceutical Applications of Graphene-based Nanosheets
Current Pharmaceutical Biotechnology Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy Targeting 5-Lipoxygenase for Prevention and Treatment of Cancer
Current Enzyme Inhibition Influence of Trishomocubanes on Sigma Receptor Binding of N-(1-Benzylpiperidin- 4-yl)-4-[123I]iodobenzamide In Vivo in the Rat Brain
Medicinal Chemistry An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Current Pharmaceutical Design Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents
Current Medicinal Chemistry Emerging Adenoviral Vectors for Stable Correction of Genetic Disorders
Current Gene Therapy Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design